Tag Archives: Injectable

Injectable HIV therapy would have to cost less than $131 a year to be cost-effective in Africa

A cost-effectiveness analysis has found that injectable, long-lasting antiretroviral therapy (ART) would need to cost no more than $ 131 a year in order to be cost-effective if used for patients who are not fully virally suppressed in lower-income settings in regions like sub-Saharan Africa. The analysis found that injectable cabotegravir/rilpivirine would only reach the… Read More »

HPTN 083: Injectable PrEP can make breakthrough infections hard to detect

Some cases of resistance, but not in people with falling cabotegravir levels after injections are stopped A detailed analysis of results from the HPTN 083 PrEP study, which compared the efficacy of a two-monthly injection of the drug cabotegravir against daily oral tenofovir disoproxil fumarate and emtricitabine (TDF/FTC) pills, confirmed that there were only a… Read More »